XAIR Beyond Air, Inc. Stock Quote

XAIR [NASD]

Index	-	P/E	-	EPS (ttm)	-1.29	Insider Own	7.70%	Shs Outstand	20.76M	Perf Week	-6.25%
Market Cap	116.33M	Forward P/E	-	EPS next Y	-0.94	Insider Trans	24.75%	Shs Float	18.35M	Perf Month	-0.58%
Income	-22.90M	PEG	-	EPS next Q	-0.21	Inst Own	21.00%	Short Float	19.66%	Perf Quarter	-9.73%
Sales	0.90M	P/S	129.26	EPS this Y	28.60%	Inst Trans	37.21%	Short Ratio	9.78	Perf Half Y	-1.54%
Book/sh	1.47	P/B	3.47	EPS next Y	6.00%	ROA	-78.40%	Target Price	-	Perf Year	-31.82%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-111.50%	52W Range	4.62 - 7.96	Perf YTD	-3.23%
Dividend	-	P/FCF	-	EPS past 5Y	-13.90%	ROI	-62.40%	52W High	-35.93%	Beta	-0.58
Dividend %	-	Quick Ratio	9.80	Sales past 5Y	-	Gross Margin	-	52W Low	10.39%	ATR	0.26
Employees	45	Current Ratio	9.80	Sales Q/Q	-92.90%	Oper. Margin	-	RSI (14)	46.31	Volatility	5.00% 4.85%
Optionable	Yes	Debt/Eq	0.17	EPS Q/Q	85.80%	Profit Margin	-	Rel Volume	1.22	Prev Close	5.13
Shortable	No	LT Debt/Eq	0.15	Earnings	Jun 10 AMC	Payout	-	Avg Volume	368.57K	Price	5.10
Recom	1.60	SMA20	-0.32%	SMA50	-3.49%	SMA200	-8.73%	Volume	448,220	Change	-0.58%

Apr-28-21

Initiated

Truist

Buy

$12

Oct-22-19

Initiated

Oppenheimer

Outperform

Jun-10-21 04:05PM	Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2021 GlobeNewswire
08:50AM	Thursdays Pre-Market: Heres What You Need to Know Before the Market Opens TipRanks
Jun-03-21 03:00PM	Will Beyond Air, Inc. (XAIR) Report Negative Earnings Next Week? What You Should Know Zacks -5.41%
May-26-21 07:30AM	Beyond Air® Reaches Settlement Agreement with Circassia for LungFit® PH GlobeNewswire
May-25-21 07:30AM	Beyond Air® Schedules Fiscal Year 2021 Financial Results Conference Call and Webcast GlobeNewswire
May-20-21 08:00AM	Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing GlobeNewswire
May-13-21 08:00AM	Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021 GlobeNewswire
May-12-21 09:27AM	What Type Of Shareholders Make Up Beyond Air, Inc.'s (NASDAQ:XAIR) Share Registry? Simply Wall St.
May-03-21 08:00AM	Beyond Air® Appoints Peter Senior as Director of Business Development GlobeNewswire -6.03%
Apr-14-21 08:00AM	Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021 GlobeNewswire
Mar-24-21 08:00AM	Beyond Air® to Present Abstracts at the American Thoracic Society Virtual Sessions in May 2021 GlobeNewswire
Mar-01-21 08:00AM	Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in March 2021 GlobeNewswire
Feb-16-21 08:00AM	Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease GlobeNewswire +7.35%
Feb-12-21 08:07AM	Does Beyond Air's (NASDAQ:XAIR) CEO Salary Compare Well With The Performance Of The Company? Simply Wall St.
Feb-09-21 04:05PM	Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update GlobeNewswire
02:30PM	Beyond Air, Inc. to Host Earnings Call ACCESSWIRE
Feb-02-21 12:31PM	Beyond Air, Inc. (XAIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jan-15-21 04:10PM	Beyond Air® Schedules Third Fiscal Quarter 2021 Financial Results Conference Call and Webcast GlobeNewswire
Jan-04-21 12:07AM	Steven Lisi Is The CEO & Chairman of the Board of Beyond Air, Inc. (NASDAQ:XAIR) And They Just Picked Up 4.3% More Shares Simply Wall St. +13.28%
Dec-07-20 08:00AM	Beyond Air® Initiates Patient Screening for LungFit GO Pilot Study for At-Home, Self-Administration of Inhaled Nitric Oxide in Nontuberculous Mycobacteria Lung Disease GlobeNewswire
Nov-27-20 02:53AM	Beyond Air (NASDAQ:XAIR) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Nov-19-20 08:00AM	Beyond Air® to Participate in the 32nd Annual Piper Sandler Healthcare Conference from December 1-3, 2020 GlobeNewswire
Nov-11-20 04:10PM	Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Business Update GlobeNewswire
02:30PM	Beyond Air, Inc. to Host Earnings Call ACCESSWIRE
07:30AM	Beyond Air® Submits Premarket Approval Application to FDA for LungFit PH to Treat Persistent Pulmonary Hypertension of the Newborn GlobeNewswire
Oct-23-20 08:00AM	Beyond Air® Schedules Second Fiscal Quarter 2021 Financial Results Conference Call and Webcast GlobeNewswire
Oct-21-20 07:00AM	Beyond Air® Approved to Initiate Clinical Study at 150 ppm Nitric Oxide with LungFit for the Treatment of Acute Viral Pneumonia Including COVID-19 GlobeNewswire
Oct-19-20 10:01AM	Beyond Air® Presents In Vivo Solid Tumor Data Confirming In Situ Cancer Vaccination with a Single Injection of Gaseous Nitric Oxide at the AACR Conference on Tumor Immunology and Immunotherapy GlobeNewswire
07:15AM	Beyond Air® Presents Data Showing Anti-Coronavirus Activity of Nitric Oxide at the CHEST Annual Meeting 2020 GlobeNewswire
07:00AM	Beyond Air® Presents Pilot Bronchiolitis Data at the CHEST Annual Meeting 2020 GlobeNewswire
Oct-16-20 08:00AM	Beyond Air® Presents Positive New Preclinical Data for the Use of a Single Injection of Gaseous Nitric Oxide as a Novel In situ Cancer Vaccination GlobeNewswire
Oct-13-20 12:33PM	Market Sentiment Around Loss-Making Beyond Air, Inc. (NASDAQ:XAIR) Simply Wall St.
Sep-30-20 08:00AM	Beyond Air® to Present Data on Nitric Oxide in the Treatment of Solid Tumors at the American Association for Cancer Research (AACR) Conference on Tumor Immunology and Immunotherapy GlobeNewswire
Sep-11-20 08:00AM	Beyond Air to Present at the Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit GlobeNewswire
Sep-09-20 08:00AM	Beyond Air® to Present Posters on CoronaVirus and Bronchiolitis at the CHEST 2020 Annual Meeting GlobeNewswire
Aug-27-20 08:59AM	What Type Of Shareholders Own The Most Number of Beyond Air, Inc. (NASDAQ:XAIR) Shares? Simply Wall St. -10.00%
08:00AM	Beyond Air® to Present New Nitric Oxide Data in an e-Poster Presentation at the North America Conference on Lung Cancer 2020 (NACLC 2020) GlobeNewswire
Aug-10-20 04:01PM	Beyond Air Publishes New Data on Nitric Oxide to Treat M. Abscessus in the Peer-Reviewed Journal Access Microbiology GlobeNewswire
Aug-06-20 07:45AM	Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2021 and Provides Business Update GlobeNewswire -8.48%
Jul-23-20 08:00AM	Beyond Air® to Announce Fiscal First Quarter 2021 Financial Results on Thursday, August 6th GlobeNewswire
Jun-22-20 04:01PM	Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020 GlobeNewswire
09:00AM	Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors GlobeNewswire
Jun-15-20 08:30AM	Beyond Air Announces First Patient Enrolled in its U.S. Study of Nitric Oxide Therapy Using the LungFit System in COVID-19 Patients GlobeNewswire +6.83%
08:00AM	Beyond Air Announces Publication of Peer-Reviewed Journal Article in Scientific Reports GlobeNewswire
Jun-08-20 05:30PM	Beyond Air Scheduled to Announce Fiscal Year 2020 Financial Results on Monday, June 22nd GlobeNewswire
Jun-03-20 09:25PM	Hedge Funds Are Warming Up To Beyond Air, Inc. (XAIR) Insider Monkey
May-26-20 08:30AM	Beyond Air Receives Approval from Health Canada to Study Nitric Oxide Generated and Delivered by the LungFit in COVID-19 Patients GlobeNewswire
May-20-20 08:30AM	Beyond Air Achieves Primary Endpoint in Pilot Bronchiolitis Study GlobeNewswire
May-15-20 08:30AM	Beyond Air to Present New Data in an e-Poster Presentation at the Upcoming AACR Virtual Annual Meeting II on June 22nd to 24th GlobeNewswire
08:25AM	Beyond Air Enters into New Common Stock Purchase Agreement Extending Relationship with Lincoln Park Capital GlobeNewswire
Apr-16-20 08:30AM	Beyond Air to Initiate Clinical Study Evaluating High Concentration Nitric Oxide for the Treatment of COVID-19 Patients in the United States GlobeNewswire -8.82%
Mar-18-20 08:30AM	Beyond Air Accelerates LungFit BRO COVID-19 Program GlobeNewswire -14.36%
Mar-16-20 08:00AM	Beyond Air Submits Investigational Device Exemption (IDE) to the United States Food and Drug Administration (FDA) for the Treatment of COVID-19 Patients GlobeNewswire +21.41%
Mar-05-20 09:00AM	Beyond Air Hosting Analyst Day Today, March 5, 2020 at 2:00 p.m. ET GlobeNewswire -14.82%
Feb-25-20 08:30AM	Beyond Air Hosting Analyst Day on March 5, 2020 GlobeNewswire -9.62%
Feb-07-20 08:30AM	Beyond Air Reports Financial Results for Fiscal Third Quarter 2020 GlobeNewswire
Jan-22-20 08:00AM	Beyond AirTM Schedules Third Fiscal Quarter 2020 Financial Results Conference Call and Webcast GlobeNewswire
Dec-22-19 07:43PM	Hedge Funds Have Never Been This Bullish On Beyond Air, Inc. (XAIR) Insider Monkey
Dec-18-19 04:03PM	Beyond Air Terminates Commercial Licensing Agreement for LungFit PH for Use in the Hospital Setting in the United States and China GlobeNewswire
Dec-12-19 04:15PM	Beyond Air, Inc. Announces Closing of $11.5 Million Public Offering and Private Placement of Common Stock and Exercise of Option to Purchase Additional Shares GlobeNewswire
Dec-10-19 09:12AM	Beyond Air Prices $10.5 Million Underwritten Offering of Common Stock and Concurrent Private Placement GlobeNewswire -12.29%
Dec-09-19 05:12PM	Beyond Air Announces Proposed Public Offering and Concurrent Private Placement GlobeNewswire
Nov-25-19 08:00AM	Beyond Air Signs Agreement with MESA Specialty Gases & Equipment for Nitric Oxide and Nitrogen Dioxide Calibration Gas Supply GlobeNewswire
Nov-06-19 04:01PM	Beyond Air Reports Financial Results for Fiscal Second Quarter 2020 GlobeNewswire -5.48%
Nov-04-19 08:00AM	Beyond Air to Attend the American Association for Respiratory Care (AARC) 2019 Congress in New Orleans GlobeNewswire
Oct-24-19 04:05PM	Beyond Air Schedules Fiscal Second Quarter 2020 Financial Results Conference Call and Webcast GlobeNewswire
Oct-22-19 04:30PM	Beyond Air to Attend the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans GlobeNewswire -6.71%
Oct-16-19 08:00AM	Beyond Air Provides Update on High Concentration Nitric Oxide (NO) Animal Studies Using LungFit GlobeNewswire
Oct-01-19 04:05PM	Beyond Air Presents Data at the 2019 European Respiratory Society (ERS) International Congress in Madrid, Spain GlobeNewswire
Sep-23-19 04:25PM	Beyond Air to Present at the Upcoming 2019 European Respiratory Society (ERS) International Congress in Madrid, Spain GlobeNewswire -7.30%
Sep-12-19 04:30PM	Beyond Air to Participate at Two Upcoming Conferences GlobeNewswire
Sep-03-19 04:59PM	Beyond Air to Present at the 21st Annual H.C. Wainwright Global Investment Conference GlobeNewswire
Aug-14-19 04:05PM	Beyond Air Reports Financial Results for Fiscal First Quarter 2020 GlobeNewswire
Aug-05-19 08:00AM	Beyond Air Participating at the BTIG Biotechnology Conference on August 12 GlobeNewswire
Jul-30-19 08:00AM	Beyond Air Schedules First Fiscal Quarter 2020 Financial Results Conference Call and Webcast GlobeNewswire

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of lung infections, persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis, and nontuberculous mycobacteria.The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Carey Robert	Director	Jun 17	Buy	5.36	350,000	1,876,000	481,418	Jun 21 04:21 PM
Lisi Steven A.	CEO and Chairman of the Board	Jun 17	Buy	5.36	25,000	134,000	1,006,487	Jun 21 04:49 PM
BECK DOUGLAS	Chief Financial Officer	Jun 16	Buy	5.38	1,000	5,380	22,460	Jun 17 04:23 PM
Carey Robert	Director	Mar 04	Buy	5.70	17,000	96,900	131,418	Mar 05 07:42 AM
Carey Robert	Director	Feb 18	Buy	6.67	15,000	100,050	114,418	Feb 18 04:11 PM
Lucera Erick	Director	Feb 16	Option Exercise	4.25	1,171	4,977	2,342	Mar 03 05:50 PM
Avniel Amir	COO and President	Feb 14	Option Exercise	4.25	2,342	9,954	353,527	Feb 17 06:32 PM
BENTSUR RON	Director	Feb 12	Option Exercise	4.25	23,419	99,531	205,855	Feb 18 04:14 PM
BENTSUR RON	Director	Feb 12	Sale	6.36	23,419	148,945	182,436	Feb 18 04:14 PM
BENTSUR RON	Director	Feb 11	Sale	6.28	1,500	9,420	182,436	Feb 18 04:14 PM
Lisi Steven A.	CEO and Chairman of the Board	Feb 10	Sale	7.07	70,388	497,735	981,487	Feb 12 04:25 PM
BENTSUR RON	Director	Jan 02	Sale	5.89	5,700	33,573	183,936	Feb 08 08:08 PM
Lisi Steven A.	CEO, Chairman	Dec 31	Buy	5.28	38,500	203,280	929	Dec 31 05:29 PM
BECK DOUGLAS	Chief Financial Officer	Dec 31	Buy	5.28	3,000	15,840	21,460	Dec 31 04:44 PM
BECK DOUGLAS	Chief Financial Officer	Sep 24	Buy	4.88	3,000	14,640	64,710	Sep 25 05:00 PM
Avniel Amir	COO and President	Aug 25	Sale	5.97	3,187	19,012	326,785	Aug 27 05:38 PM
BENTSUR RON	Director	Aug 25	Sale	5.95	1,580	9,406	189,636	Aug 27 05:40 PM
Carey Robert	Director	Aug 24	Buy	5.70	10,000	57,000	99,418	Aug 26 05:00 PM
Avniel Amir	COO and President	Aug 24	Sale	5.68	7,778	44,209	329,972	Aug 25 09:00 PM
BENTSUR RON	Director	Aug 24	Sale	5.68	3,889	22,104	191,216	Aug 25 09:00 PM
Avniel Amir	COO and President	Aug 21	Sale	6.05	6,491	39,295	337,750	Aug 25 09:00 PM
BENTSUR RON	Director	Aug 21	Sale	6.05	3,246	19,651	195,105	Aug 25 09:00 PM
Avniel Amir	COO and President	Aug 20	Sale	6.29	7,555	47,553	344,241	Aug 21 05:00 PM
BENTSUR RON	Director	Aug 20	Sale	6.29	3,778	23,780	198,351	Aug 21 05:00 PM
Avniel Amir	COO and President	Aug 19	Sale	6.32	13,067	82,538	351,796	Aug 21 05:00 PM
BENTSUR RON	Director	Aug 19	Sale	6.32	6,533	41,266	202,129	Aug 21 05:00 PM
Avniel Amir	COO and President	Aug 18	Sale	5.83	9,155	53,376	364,863	Aug 19 05:00 PM
BENTSUR RON	Director	Aug 18	Sale	5.83	4,578	26,691	208,662	Aug 19 05:00 PM
Avniel Amir	COO and President	Aug 17	Sale	5.72	8,827	50,458	374,018	Aug 18 05:00 PM
BENTSUR RON	Director	Aug 17	Sale	5.72	4,413	25,226	213,240	Aug 18 05:00 PM
Carey Robert	Director	Aug 14	Buy	5.62	60,000	337,500	89,418	Aug 18 05:00 PM
Lisi Steven A.	CEO, Chairman	Aug 14	Buy	5.55	20,000	110,940	890,763	Aug 18 05:00 PM
Avniel Amir	COO and President	Aug 14	Sale	5.52	13,364	73,745	382,845	Aug 17 06:50 PM
BENTSUR RON	Director	Aug 14	Sale	5.53	6,680	36,932	217,653	Aug 17 06:51 PM
Carey Robert	Director	Aug 13	Buy	5.38	10,000	53,750	29,418	Aug 17 06:51 PM
BENTSUR RON	Director	Aug 13	Sale	5.50	4,088	22,494	224,333	Aug 14 05:40 PM
Avniel Amir	COO and President	Aug 13	Sale	5.50	8,179	45,005	396,209	Aug 14 05:36 PM
BENTSUR RON	Director	Aug 12	Sale	5.30	4,689	24,834	228,421	Aug 13 04:30 PM
Avniel Amir	COO and President	Aug 12	Sale	5.30	9,378	49,669	404,388	Aug 13 04:30 PM
Avniel Amir	COO and President	Aug 11	Sale	5.51	7,825	43,133	413,766	Aug 12 08:35 PM
BENTSUR RON	Director	Aug 11	Sale	5.51	3,910	21,553	233,110	Aug 12 08:24 PM
Avniel Amir	COO and President	Aug 10	Sale	5.42	6,900	37,386	421,591	Aug 12 08:35 PM
BENTSUR RON	Director	Aug 10	Sale	5.42	3,437	18,636	237,020	Aug 12 08:24 PM
BENTSUR RON	Director	Aug 07	Sale	5.35	10,222	54,657	245,374	Aug 10 06:06 PM
Avniel Amir	COO and President	Aug 07	Sale	5.35	20,493	109,619	438,391	Aug 10 06:03 PM
Avniel Amir	COO and President	Aug 06	Sale	5.94	12,391	73,570	458,884	Aug 07 08:53 PM
BENTSUR RON	Director	Aug 06	Sale	5.94	6,192	36,777	255,596	Aug 07 08:53 PM
Avniel Amir	COO and President	Aug 05	Sale	6.15	7,233	44,498	471,275	Aug 07 08:53 PM
BENTSUR RON	Director	Aug 05	Sale	6.16	3,619	22,286	261,788	Aug 07 08:53 PM
BENTSUR RON	Director	Aug 04	Sale	6.13	3,649	22,369	265,407	Aug 06 05:00 PM
Avniel Amir	COO and President	Aug 04	Sale	6.13	7,300	44,725	478,508	Aug 05 06:13 PM
BENTSUR RON	Director	Aug 03	Sale	6.16	3,814	23,489	269,056	Aug 04 05:05 PM
Avniel Amir	COO and President	Aug 03	Sale	6.16	7,600	46,794	485,808	Aug 05 06:13 PM
BENTSUR RON	Director	Jul 31	Sale	6.27	2,868	17,970	272,870	Aug 04 05:05 PM
Avniel Amir	COO and President	Jul 31	Sale	6.26	5,800	36,321	493,408	Aug 03 04:30 PM
Avniel Amir	COO and President	Jul 30	Sale	6.26	6,800	42,568	499,208	Aug 03 04:30 PM
BENTSUR RON	Director	Jul 30	Sale	6.26	3,418	21,404	275,738	Jul 31 06:26 PM
BENTSUR RON	Director	Jul 29	Sale	6.16	4,343	26,731	279,156	Jul 31 06:26 PM
Avniel Amir	COO and President	Jul 29	Sale	6.10	1,433	8,744	506,008	Jul 30 08:23 PM
Avniel Amir	COO and President	Jul 29	Sale	6.10	2,101	12,821	507,441	Jul 30 08:23 PM
Avniel Amir	COO and President	Jul 28	Sale	6.20	5,000	31,001	509,542	Jul 30 08:23 PM
Avniel Amir	COO and President	Jul 27	Sale	6.26	9,900	61,966	504,642	Aug 12 08:33 PM
BENTSUR RON	Director	Jul 27	Sale	6.27	4,917	30,807	278,582	Aug 12 08:19 PM
Lisi Steven A.	CEO, Chairman	Jun 25	Buy	7.45	35,000	260,750	870,763	Jun 29 08:30 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience